Macrophage Inhibitory Cytokine 1 Biomarker Serum Immunoassay in Combination with PSA Is a More Specific Diagnostic Tool for Detection of Prostate Cancer

Open Access

Peer-reviewed

Research Article

Ji Li,

Affiliation PharmaSeq, Inc., Monmouth Junction, New Jersey, United States of America
⨯
Robert W. Veltri,

Affiliation Johns Hopkins University School of Medicine (JHUSOM), Baltimore, Maryland, United States of America
⨯
Zhen Yuan,

Affiliation PharmaSeq, Inc., Monmouth Junction, New Jersey, United States of America
⨯
Christhunesa S. Christudass,

Current address: Christian Medical College, Vellore, India

Affiliation Johns Hopkins University School of Medicine (JHUSOM), Baltimore, Maryland, United States of America
⨯
Wlodek Mandecki

* E-mail: mandecki@pharmaseq.com

Affiliation PharmaSeq, Inc., Monmouth Junction, New Jersey, United States of America
⨯

Reader Comments (0)

Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Immunoassays
Is the Subject Area "Immunoassays" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Cancer detection and diagnosis
Is the Subject Area "Cancer detection and diagnosis" applicable to this article?

Thanks for your feedback.
Biomarkers
Is the Subject Area "Biomarkers" applicable to this article?

Thanks for your feedback.
Biopsy
Is the Subject Area "Biopsy" applicable to this article?

Thanks for your feedback.
Prostate gland
Is the Subject Area "Prostate gland" applicable to this article?

Thanks for your feedback.
Recombinant proteins
Is the Subject Area "Recombinant proteins" applicable to this article?

Thanks for your feedback.